Precision Biologics

About:

Precision Biologics develops therapeutic and diagnostic products for the early detection and treatment of cancer.

Website: http://precision-biologics.com

Twitter/X: nciresearchctr

Top Investors: NantWorks

Description:

Precision Biologics is a clinical stage biotechnology corporation focused on developing therapeutic and diagnostic products for the early detection and treatment of cancer. The company’s antibody drug candidates and diagnostics are designed to detect and target the tumor without destroying healthy cells. Precision Biologics is uniquely positioned to create innovative therapeutics through the use of proprietary cancer vaccines, several of which have demonstrated success in human trials.

Total Funding Amount:

$59.4M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Dallas, Texas, United States

Founded Date:

2012-02-01

Contact Email:

info(AT)precision-biologics.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2015-10-16

IPO Status:

Private

Industries:

© 2025 bioDAO.ai